Chris Cashman of Marinus Pharmaceuticals Inc. joined us for World Orphan Drug Conference USA 2015 to present about ‘ Leading Innovation in Treatment of Epilepsy and Neuropsychiatric Disorders’
Download the presentation to learn about:
- Ganaxalone: First-In-Class Therapeutic for Epilepsy and Neuropsychiatric Disorders
- Diversified Clinical Stage Opportunities
- Behaviors in Fragile X Syndrome
- Intravenous Formulation
…and much more!
Get your copy here!
To find out more about Marinus Pharmaceuticals and Gaxalone , attend World Orphan Drug Congress USA 2016 April 20-22 in Washington, DC.